A Phase IIa, Multi-center, Multi-national, Open Label, Dose Ranging Study of the Efficacy, Safety, and Tolerability of Oral DU-176b Administered Once or Twice Daily in the Treatment of Adult Patients Undergoing Total Hip Arthroplasty
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Edoxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Sponsors Daiichi Pharmaceutical; Daiichi Sankyo Inc
- 12 Dec 2007 Status changed from in progress to completed
- 09 Oct 2005 New trial record.